Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School

Last Updated: January 28, 2020

DrugPatentWatch Database Preview

Invagen Pharms Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for INVAGEN PHARMS, and what generic and branded alternatives to INVAGEN PHARMS drugs are available?

INVAGEN PHARMS has fifty-seven approved drugs.

There is one tentative approval on INVAGEN PHARMS drugs.

Summary for Invagen Pharms
US Patents:0

Drugs and US Patents for Invagen Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Invagen Pharms QUINAPRIL HYDROCHLORIDE quinapril hydrochloride TABLET;ORAL 078457-004 Aug 24, 2007 AB RX No No   Start Trial   Start Trial
Invagen Pharms OLANZAPINE olanzapine TABLET;ORAL 203333-001 Mar 15, 2016 AB RX No No   Start Trial   Start Trial
Invagen Pharms RIZATRIPTAN BENZOATE rizatriptan benzoate TABLET;ORAL 204339-001 Jul 1, 2013 AB RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:


Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.